Sylentis Competitors and Similar CompaniesClear all

Sylentis's competitors and similar companies include Intellia Therapeutics, Lexicon Pharmaceuticals, Omega Therapeutics and AnGes.

	Sylentis Sylentis is a biotechnology company focused on the development of ophthalmic drugs and therapies based on RNAi (gene silencing) technology.	Intellia Therapeutics Intellia Therapeutics is a genome editing company that caters to the biotechnology industry.	Lexicon Pharmaceuticals Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.	Omega Therapeutics Omega Therapeutics is an epigenomic medicine company.	AnGes AnGes is a biopharmaceutical company specializing in R&D and practical application of genetic medicine.
Founding Date	Founding Date 2006	Founding Date 2014	Founding Date 1995	Founding Date 2017	Founding Date 1999
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech clinical research healthtech	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma	Tags Healthcare biotech drug development genetics pharma
Locations	Locations Tres Cantos, ES HQ Madrid, ES Mountain View, US	Locations Cambridge, US HQ	Locations The Woodlands, US HQ Jersey, JE Atlanta, US Bernards, US Birmingham, US Boston, US Charlotte, US see more	Locations Cambridge, US HQ	Locations Ibaraki, JP HQ Fujisawa, JP Ibaraki, JP Kawasaki, JP Minato City, JP Bethesda, US
Employees	Employees 51	Employees 40323% decrease	Employees 20216% increase	Employees 60	Employees 5562% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.7 b	Valuation ($) 737.4 m	Valuation ($) 68.4 m	Valuation ($) 78.3 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $67.7m (FY, 2025)	Revenue (est.) $49.8m (FY, 2025)	Revenue (est.) $3.1m (FY, 2023)	Revenue (est.) ¥874.1m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $274k (FY, 2025)	Cost of goods N/A	Cost of goods ¥499.9m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $49.5m (FY, 2025)	Gross profit N/A	Gross profit ¥374.2m (FY, 2025)
Net income	Net income N/A	Net income ($412.7m) (FY, 2025)	Net income ($50.3m) (FY, 2025)	Net income ($97.4m) (FY, 2023)	Net income (¥5.1b) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 244.7m	Total funding raised $ 211m	Total funding raised N/A